We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-2.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.5B
AUM Growth
-$124M
(-0.71%)
Cap. Flow
-$427M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
21.6%
Holding
1,393
New
110
Increased
432
Reduced
589
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$68.9M |
| 2 |
Applied Materials
AMAT
|
+$65.9M |
| 3 |
Netflix
NFLX
|
+$53.9M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$51.8M |
| 5 |
Ross Stores
ROST
|
+$50.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$72.2M |
| 2 |
CDW
CDW
|
+$64.9M |
| 3 |
Parker-Hannifin
PH
|
+$58.7M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$51.4M |
| 5 |
Genuine Parts
GPC
|
+$46.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 9.82% |
| 4 | Financials | 9.37% |
| 5 | Industrials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ameris Bancorp
ABCB
$5.9B
| $12M | 0.07% |
311,939
-3,157
| -1% | -$126K |
|
302
Allstate
ALL
$70.1B
| $11.7M | 0.07% |
105,463
+2,590
| +3% | +$283K |
|
303
Integra LifeSciences
IART
$1.54B
| $11.7M | 0.07% |
306,032
+95,857
| +46% | +$4.03M |
|
304
Radian Group
RDN
$5.22B
| $11.6M | 0.07% |
462,868
-4,889
| -1% | -$129K |
|
305
Baxter International
BAX
$12.6B
| $11.6M | 0.07% |
307,638
-99,163
| -24% | -$4.22M |
|
306
Public Service Enterprise Group
PEG
$39.3B
| $11.6M | 0.07% |
203,306
+156,887
| +338% | +$9.64M |
|
307
Globus Medical
GMED
$10.9B
| $11.5M | 0.07% |
+231,974
| New | +$13M |
|
308
Qorvo
QRVO
$8.09B
| $11.5M | 0.07% |
120,449
+84,513
| +235% | +$8.63M |
|
|
EFOR
309
Everforth Inc
EFOR
$953M
| $11.5M | 0.07% |
140,493
-8,805
| -6% | -$701K |
|
310
Stewart Information Services
STC
$2.12B
| $11.5M | 0.07% |
261,983
-4,070
| -2% | -$184K |
|
311
RLJ Lodging Trust
RLJ
$1.89B
| $11.3M | 0.06% |
+1,156,723
| New | +$11.5M |
|
312
Norfolk Southern
NSC
$76.1B
| $11.3M | 0.06% |
57,277
+6,159
| +12% | +$1.33M |
|
313
Ziff Davis
ZD
$1.95B
| $11.2M | 0.06% |
175,694
+58,448
| +50% | +$4.01M |
|
314
Equifax
EFX
$22B
| $11.2M | 0.06% |
61,062
+4,856
| +9% | +$991K |
|
315
New Jersey Resources
NJR
$6.04B
| $11.2M | 0.06% |
274,757
-15,433
| -5% | -$676K |
|
316
Maravai LifeSciences
MRVI
$1.01B
| $11.1M | 0.06% |
1,108,554
+688,403
| +164% | +$7.56M |
|
317
iShares Russell 1000 Value ETF
IWD
$82.2B
| $11.1M | 0.06% |
72,827
-9,452
| -11% | -$1.5M |
|
|
FL
318
DELISTED
Foot Locker
FL
| $11M | 0.06% |
636,235
+190,642
| +43% | +$4.26M |
|
319
Unum
UNM
$14B
| $11M | 0.06% |
223,229
+32,454
| +17% | +$1.59M |
|
320
Virtu Financial
VIRT
$5.11B
| $10.9M | 0.06% |
629,349
-8,530
| -1% | -$155K |
|
321
Grocery Outlet
GO
$902M
| $10.9M | 0.06% |
376,199
-2,406
| -0.6% | -$76.5K |
|
322
Energizer
ENR
$1.5B
| $10.7M | 0.06% |
335,402
-7,647
| -2% | -$262K |
|
323
Under Armour
UAA
$3.04B
| $10.7M | 0.06% |
+1,567,970
| New | +$11.8M |
|
324
Pacira BioSciences
PCRX
$1.05B
| $10.7M | 0.06% |
347,222
+51,877
| +18% | +$1.87M |
|
325
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.33B
| $10.6M | 0.06% |
110,610
-20
| -0% | -$1.96K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2023 Portfolio in Review
As of Q3 2023, Glenmede Trust held 1,393 positions worth $17.5B, down 0.71% from $17.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Glenmede Trust's Q3 2023 filing shows 110 new, 432 increased, 589 reduced and 137 closed positions. Its largest new stake was Kenvue: 1,442,581 shares worth $29M. The largest sale was Synopsys, an estimated $72.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Glenmede Trust's largest Q3 2023 buy was Kenvue: 1,442,581 shares worth $29M.
- Glenmede Trust added most to TJX Companies in Q3 2023, an estimated $68.9M increase.
- Glenmede Trust's biggest Q3 2023 reduction was Synopsys, cutting an estimated $72.2M.
- Glenmede Trust fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $21.6M.
- Glenmede Trust's ten largest holdings make up 22% of its $17.5B portfolio in Q3 2023.
- Glenmede Trust opened 110 new positions and closed 137 in Q3 2023.
- Glenmede Trust's portfolio value fell 0.71% quarter-over-quarter to $17.5B.
Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.